38521860|t|Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease.
38521860|a|Meta-analysis of genome-wide association study data has implicated PDE4B in the pathogenesis of Alzheimer's disease (AD), the leading cause of senile dementia. PDE4B encodes one of four subtypes of cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase-4 (PDE4A-D). To interrogate the involvement of PDE4B in the manifestation of AD-related phenotypes, the effects of a hypomorphic mutation (Pde4bY358C) that decreases PDE4B's cAMP hydrolytic activity were evaluated in the AppNL-G-F knock-in mouse model of AD using the Barnes maze test of spatial memory, 14C-2-deoxyglucose autoradiography, thioflavin-S staining of beta-amyloid (Abeta) plaques, and inflammatory marker assay and transcriptomic analysis (RNA sequencing) of cerebral cortical tissue. At 12 months of age, AppNL-G-F mice exhibited spatial memory and brain metabolism deficits, which were prevented by the hypomorphic PDE4B in AppNL-G-F/Pde4bY358C mice, without a decrease in Abeta plaque burden. RNA sequencing revealed that, among the 531 transcripts differentially expressed in AppNL-G-F versus wild-type mice, only 13 transcripts from four genes - Ide, Btaf1, Padi2, and C1qb - were differentially expressed in AppNL-G-F/Pde4bY358C versus AppNL-G-F mice, identifying their potential involvement in the protective effect of hypomorphic PDE4B. Our data demonstrate that spatial memory and cerebral glucose metabolism deficits exhibited by 12-month-old AppNL-G-F mice are prevented by targeted inhibition of PDE4B. To our knowledge, this is the first demonstration of a protective effect of PDE4B subtype-specific inhibition in a preclinical model of AD. It thus identifies PDE4B as a key regulator of disease manifestation in the AppNL-G-F model and a promising therapeutic target for AD.
38521860	21	26	PDE4B	Gene	18578
38521860	74	79	mouse	Species	10090
38521860	90	109	Alzheimer's disease	Disease	MESH:D000544
38521860	178	183	PDE4B	Gene	18578
38521860	207	226	Alzheimer's disease	Disease	MESH:D000544
38521860	228	230	AD	Disease	MESH:D000544
38521860	254	269	senile dementia	Disease	MESH:D000544
38521860	271	276	PDE4B	Gene	18578
38521860	421	426	PDE4B	Gene	18578
38521860	451	453	AD	Disease	MESH:D000544
38521860	518	523	Y358C	ProteinMutation	tmVar:p|SUB|Y|358|C;HGVS:p.Y358C;VariantGroup:0;OriginalGene:15925;CorrespondingGene:3416;RS#:776060091;CorrespondingSpecies:10090
38521860	540	545	PDE4B	Gene	18578
38521860	614	619	mouse	Species	10090
38521860	629	631	AD	Disease	MESH:D000544
38521860	678	696	14C-2-deoxyglucose	Chemical	-
38521860	714	726	thioflavin-S	Chemical	MESH:C009462
38521860	753	758	Abeta	Gene	11820
38521860	773	785	inflammatory	Disease	MESH:D007249
38521860	904	908	mice	Species	10090
38521860	927	963	memory and brain metabolism deficits	Disease	MESH:D001928
38521860	1005	1010	PDE4B	Gene	18578
38521860	1035	1039	mice	Species	10090
38521860	1063	1068	Abeta	Gene	11820
38521860	1195	1199	mice	Species	10090
38521860	1239	1242	Ide	Gene	15925
38521860	1244	1249	Btaf1	Gene	107182
38521860	1251	1256	Padi2	Gene	18600
38521860	1262	1266	C1qb	Gene	12260
38521860	1317	1322	Y358C	ProteinMutation	tmVar:p|SUB|Y|358|C;HGVS:p.Y358C;VariantGroup:0;OriginalGene:15925;CorrespondingGene:3416;RS#:776060091;CorrespondingSpecies:10090
38521860	1340	1344	mice	Species	10090
38521860	1426	1432	PDE4B.	Gene	18578
38521860	1478	1514	cerebral glucose metabolism deficits	Disease	MESH:D044882
38521860	1551	1555	mice	Species	10090
38521860	1596	1602	PDE4B.	Gene	18578
38521860	1679	1684	PDE4B	Gene	18578
38521860	1739	1741	AD	Disease	MESH:D000544
38521860	1762	1767	PDE4B	Gene	18578
38521860	1874	1876	AD	Disease	MESH:D000544
38521860	Association	MESH:C009462	11820
38521860	Association	107182	18578
38521860	Association	MESH:D001928	18578
38521860	Association	15925	18578
38521860	Association	12260	18578
38521860	Association	18578	18600
38521860	Association	MESH:D000544	18578
38521860	Association	MESH:D044882	18578

